About Arkin Bio fuels life sciences breakthroughs as part of Arkin Capital’s multi-stage platform, targeting early- and mid-stage biotech innovation in immunotherapy, novel therapeutics, diagnostics, and digital health, leveraging deep pharmaceutical heritage to scale companies toward global impact.
Arkin Bio fuels biotech and health tech innovation through early-stage venture capital, supporting novel therapeutics, diagnostics, and digital health solutions that accelerate medical progress.
Run by long-tenured public market investors with deep expertise in fundamental equity research, portfolio management, and risk-adjusted capital allocation.